FITLIFE BRANDS, INC.
FTLFNasdaq
$11.06
↓ -0.9%Jul 17 close · end-of-day
Price
1Y↓ -15.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$110.5M
Enterprise Value
$110.5M
P/E
65.1
P/S
4.4
P/B
2.4
EV/EBITDA
29.8
PEG
—
FCF Yield
6.9%
Dividend Yield
—
Revenue (TTM)
$25.3M
Net Income (TTM)
$6.0M
Free Cash Flow (TTM)
$7.6M
Gross Margin
37.6%
Operating Margin
12.1%
Net Margin
23.8%
ROE
13.3%
ROIC
4.9%
Debt / Equity
—
Net Cash
—
Return 1Y
-16.6%
Company profile
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize.
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 20
- Headquarters
- Nebraska
- Website
- fitlifebrands.com
Earnings
FTLF Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$25.3M↑ +58.9%
Diluted EPS$0.17↓ -15.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $21.7M | $27.9M | $28.8M | $52.7M | $64.5M | $15.9M |
| Gross profit | $9.5M | $12.5M | $12.0M | $21.4M | $28.1M | $6.9M |
| Operating income | $4.3M | $6.2M | $5.7M | $7.5M | $13.1M | $3.0M |
| Net income | $8.8M | $5.4M | $4.4M | $5.3M | $9.0M | $6.3M |
| Diluted EPS | $7.76 | $1.13 | $0.89 | $0.54 | $0.91 | $0.20 |
| Operating cash flow | $5.7M | $4.5M | $4.1M | $4.2M | $9.6M | $7.4M |
| Free cash flow | — | — | $4.1M | $4.1M | $9.6M | $7.4M |
| Gross margin | 43.9% | 44.8% | 41.8% | 40.7% | 43.6% | 43.1% |
| Operating margin | 20.0% | 22.3% | 19.8% | 14.3% | 20.3% | 18.6% |
| Net margin | 40.6% | 19.4% | 15.4% | 10.0% | 13.9% | 39.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.9M | $16.0M | $15.0M | $15.9M | $16.1M | $23.5M | -$39.6M | $25.3M |
| Gross profit | $7.6M | $7.0M | $6.2M | $6.9M | $6.9M | $8.7M | -$15.6M | $9.5M |
| Operating income | $3.7M | $3.2M | $2.9M | $3.0M | $2.5M | $2.3M | -$4.8M | $3.1M |
| Net income | $2.6M | $2.1M | $2.1M | $2.0M | $1.7M | $921,000.00 | $1.6M | $1.7M |
| Diluted EPS | $0.27 | $0.21 | $0.22 | $0.20 | $0.18 | $0.09 | -$0.27 | $0.17 |
| Operating cash flow | $1.6M | $2.0M | $957,000.00 | $2.3M | $1.2M | $3.7M | $244,000.00 | $2.5M |
| Free cash flow | $1.6M | $2.0M | $957,000.00 | $2.3M | $1.2M | $3.7M | $239,000.00 | $2.5M |
| Gross margin | 44.8% | 43.8% | 41.4% | 43.1% | 42.8% | 37.2% | 39.5% | 37.6% |
| Operating margin | 21.7% | 19.9% | 19.2% | 18.6% | 15.6% | 9.9% | 12.2% | 12.1% |
| Net margin | 15.5% | 13.3% | 13.8% | 12.7% | 10.8% | 3.9% | -4.1% | 6.8% |
Company news
Jun 27, 2026
May 27, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-10 | Dawson Grant Robert | Buy | 3,000 | $9.98 | $29,940.00 | filing |
| 2026-04-10 | Lingenbrink Matthew | Buy | 3,000 | $9.76 | $29,280.00 | filing |
| 2026-01-15 | Yakatan Seth | Buy | 164 | $15.36 | $2,519.06 | filing |
Latest 3 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.